Top Pharmaceuticals stocks in Europe
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
NOVO BNovo Nordisk A/S | DKK3.75tn | 44.78 | 1.11% |
AZNAstraZeneca | £186.80bn | 48.34 | 1.92% |
ROGRoche Holding AG | CH₣173.24bn | 12.08 | 4.42% |
RORoche Holding AG | CH₣173.24bn | 13.09 | 4.07% |
NOVNNovartis AG | CH₣172.11bn | 16.97 | 4.04% |
SANSanofi SA | €114.25bn | 17.28 | 4.12% |
GSKGSK | £71.85bn | 13.72 | 3.4% |
MRKMerck KGaA | €66.09bn | 19.82 | 1.45% |
HLNHALEON | £30.13bn | 19.55 | 1.82% |
BAYNBayer AG | €27.53bn | 4.37 | 0.39% |
UCBUCB SA | €22.86bn | 86.12 | 0.79% |
SDZSandoz AG | CH₣13.33bn | 12.14 | 1.56% |
RECRecordati Industria Chimica E Farmaceutica SpA | €10.45bn | 29.5 | 2.36% |
IPNIpsen SA | €9.47bn | 21.78 | 1.05% |
SOBISwedish Orphan Biovitrum AB (publ) | SEK95.16bn | 35.9 | n/a |
GRFGrifols SA | €6.04bn | 17.27 | n/a |
DPHDechra Pharmaceuticals | £4.40bn | 67.15 | n/a |
ORNBVOrion Oyj | €5.07bn | 23.34 | 4.49% |
HIKHikma Pharmaceuticals | £4.35bn | 11.11 | 2.95% |
CLS1McKesson Europe AG | €4.96bn | n/a | n/a |